Why the study?
Does candesartan improve LV function and reduce infarct size in a dog model of reperfused myocardial infarction?
Population
30 dogs with reperfused anterior infarction (90 minutes ischaemia, 120 minutes reperfusion)
Comparison
Candesartan alone or after intracoronary… vs Controls
Design
Preclinical
Follow-up
120 minutes reperfusion
Authors
Loading...
AT1 blockade may confer AT2-mediated cardioprotection in canine reperfused MI; leaves open translation to human patients.
Does candesartan improve LV function and reduce infarct size in a dog model of reperfused myocardial infarction?
AT1-receptor blockade with candesartan provides cardioprotection during ischaemia-reperfusion injury via AT2-receptor activation and signalling through bradykinin, PKCε, and cGMP.
Jugdutt et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: